Agilon Health, Inc. · NYSE:AGL
Agilon Health — Q4 2024 Earnings Presentation
12 slides from Agilon Health's earnings presentation, Feb 25, 2025
Slide 1: Fourth Quarter 2024 Earnings Results
Fourth Quarter 2024 Earnings Results February 25, 2025 Copyright © 2024 agilon health
Slide 2: Disclaimers and Forward-Looking Statements
Disclaimers and Forward-Looking Statements FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION Statements in this presentation that are not historical factual statements are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Slide 3: Key Takeaways
Key Takeaways Strengthening the business for long-term success Strategic actions combined with cost discipline to help drive near-term improvement and sustainable long- term profitability Disciplined growth balancing near-term market challenges and optimizing long-term opportunity Investing in advan
Slide 4: 2024 Financial Performance
2024 Financial Performance Quarter Ending Year Ending December 31, 2024 December 31, 2024 Medicare Advantage Members 527,000 527,000 ACO REACH Members 132,000 132,000 Total Members Live on Platform 659,000 659,000 Avg. Medicare Advantage Members 527,000 522,000 Total Revenues ($M) $1,522 $6,061 Gros
Slide 5: Financial Outlook
Financial Outlook Quarter Ending Year Ending March 31, 2025 December 31, 2025 Medicare Advantage Members 490,000 – 510,000 490,000 – 520,000 ACO REACH Members 105,000 – 115,000 105,000 – 115,000 Total Members Live on Platform 595,000 – 625,000 595,000 – 635,000 Avg. Medicare Advantage Members 490,00
Slide 6: Membership Bridge FY2024 to 2025 Guide
Membership Bridge FY2024 to 2025 Guide Membership Guidance Bridge for Full Year 2025 MA Membership REACH Membership • Discipline and smart growth also applied to REACH. • Smart growth (partnership/contract exits paired with measured future growth). • Partnership exits includes completion of the Hawa
Slide 7: Medical Cost Trend Bridge – FY2024 to 2025 Guide
Medical Cost Trend Bridge – FY2024 to 2025 Guide Medical Cost Guidance Bridge for Full Year 2025 Key Highlights • The 2025 medical cost projections assume that the elevated utilization seen in 2024 will continue. • 2024 closed with a 6.8% medical cost trend, which we estimate has 50 basis points ass
Slide 8: Medical Margin Bridge – FY2024 to 2025 Guide
Medical Margin Bridge – FY2024 to 2025 Guide Medical Margin Guidance Bridge for Full Year 2025 2025 Key Highlights • Focused on balanced growth prioritizing margin maturation: • Strategic exit of select partnerships/contracts create a step-up in baseline earnings. • Smaller class of ‘25 primarily “g
Slide 9: Adjusted EBITDA Bridge - FY2024 to 2025 Guide
ADJUSTED EBITDA Bridge - FY2024 to 2025 Guide Adjusted EBITDA Guidance Bridge for Full Year 2025 2025 Key Highlights • Strategic exit of select partnerships/contracts creates a larger step-up in baseline Adjusted EBITDA (the drag to Adjusted EBITDA was greater than medical margin due to correspondin
Slide 10: Appendix
Appendix Copyright © 2024 agilon health 10
Slide 11: Non-GAAP Reconciliations: Medical Margin
Non-GAAP Reconciliations Medical Margin (Dollars in thousands) Three Months Ended Twelve Months Ended December 2024 December 2024 Gross profit(1) $ (38,255) $ 4,841 Other operating revenue (3,242) (12,815) Other medical expenses 42,063 213,159 Medical margin $ 566 $ 205,185 1) Gross profit is define
Slide 12: Non-GAAP Reconciliations: Adjusted EBITDA
Non-GAAP Reconciliations Adjusted EBITDA (Dollars in thousands) Three Months Ended Twelve Months Ended December 2024 December 2024 Net income (loss)(1) $ (105,790) $ (260,101) (Income) loss from discontinued operations, net of income taxes (640) 9,824 Interest expense 1,574 6,177 Income tax expense